Werner Siemens Imaging Center

-         Funding Agency: Werner Siemens-Foundation, Zug, Switzerland

-         Applicant: Prof. Dr. Bernd Pichler

-         Funding period: 2016 – 2023

 

"Image-Guided and Functionally Instructed Tumor Therapies (iFIT)"

-         Funding Agency: DFG - Excellence Strategy by the German Federal and State Governments

-         Applicants: Prof. Dr. Lars Zender, Prof. Dr. Bernd Pichler, Prof. Dr. Hans-Georg Rammensee

-         Funding period: 2019 – 2025

 

"Immune-Image: A platform for generation, systematic selection and clinical validation of immunotracers"

-         Funding Agency: EU

-         Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling

-         Funding period: 2019 – 2024

 

"The skin as a sensor and effector organ orchestrating local and systemic immune responses (SFB CRC TRR 156)"

-          Subproject C03: "Impact of reactive oxygen species and NF-kB signaling during hapten- induced skin inflammation"

-         Funding Agency: DFG

-         Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling

-         Funding period (2. funding period): 01.07.2019-30.06.2023

 

"Investigation of a potential new PET tracer for alpha-synuclein pathology in the brain"

-          Funding Agency: Michael J. Fox Foundation

-          Principal Investigator: Dr. Kristina Herfert

-          Funding period: 01.10.2018-31.01.2020

 

"PET Imaging of Alpha-Synuclein Fibril Formatio (PET-AlphaSy)"

-          Funding Agency: EU

-          Principal Investigators: Prof. Dr. Bernd Pichler, Dr. Kristina Herfert, Dr. Andreas Maurer

-          Funding period: 01.09.2018-31.08.2022

 

"Targeting therapeutic windows in essential cellular processes for tumor therapy ( SFB FOR 2314)"

-          Subproject Z02: "Multiparametric Imaging and Molecular Probed Design Platform"

-          Subproject TP 01: "Therapeutic Induction and Image Guided Exploration of Cellular senescence for Cancer Therapy"

-          Funding Agency: DFG

-          Subproject Z02 Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Antti Poso

-          Subproject TP 01 Leaders: Prof. Dr. Bernd Pichler, Prof. Dr. Lars Zender 

-          Funding period (2. funding period): 16.07.2018-15.07.2021

 

"Platelets – Molecular, cellular and systemic functions in health and disease (SFB TRR 240)"

-         Subproject Z04: "Metabolic Imaging"

-         Funding Agency: DFG

-         Subproject leader: Prof. Dr. Bernd Pichler

-         Funding period: 01.07.2018 – 30.06.2022

 

"Innovative Training Network towards raising and supporting the next generation of creative and entrepreneurial cross-speciality imaging experts (HYBRID)”

-          Funding Agency: EU

-          Principal Investigator: Prof. Dr. Bernd Pichler

-          Funding period: 01.10.2017-30.09.2021

 

"Trimodal imaging of human brain networks using simultaneous PET/MR/EEG"

-          Funding Agency: DFG

-          Applicants: Prof. Dr. Christian la Fougère, Prof. Dr. Niels Focke, Prof. Dr. Bernd Pichler

-          Funding period: 01.03.2018-28.02.2021



"Nicht-invasive Visualisierung und Verfolgung spezifischer Zellpopulationen mittels Positronen-Emissions-Tomographie"

-          Funding Agency: Dr. Karl Helmuth Eberle-Stiftung

-          Principal Investigators: Prof. Dr. Robert Feil, Prof. Dr. Bernd Pichler, Dr. Susanne Feil

-          Funding period: 01.12.2017-30.11.2020

 

"Radiolabeled benzoxazinoles - a unique ß-amyloid PET-tracer class allowing the dichotomous detection of parenchymal and vascular ß-amyloid deposits"

-          Funding Agency: DFG

-          Applicant: Prof. Dr. Bernd Pichler

-          Funding period: 01.02.2017-31.01.2020

 

 "The skin as a sensor and effector organ orchestrating local and systemic immune (SFB TRR 156)"

-          Subproject C03: "Impact of reactive oxygen species and NF-kB signaling during hapten- induced skin inflammation"

-          Funding Agency: DFG

-          Subproject leaders: Prof. Dr. Bernd Pichler, Dr. Manfred Kneilling

-          Funding period (1. funding period): 01.07.2015-30.06.2019

 

"Innovative cancer therapy management: First in human senescence imaging (SenPET)"

-          Funding Agency: EU

-          Applicant: Prof. Dr. Bernd Pichler

-          Funding period: 01.04.2018 bis 30.09.2019